Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations-Reference-Cited by-同舟云学术

Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations

Published:2019-05 Issue:5 Volume:29 Page:1135-1150.e6
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Adebayo Michael Adeola O.,Ko Sungjin,Tao Junyan,Moghe Akshata,Yang Hong,Xu Meng,Russell Jacquelyn O.,Pradhan-Sundd Tirthadipa,Liu Silvia,Singh Sucha,Poddar Minakshi,Monga Jayvir S.,Liu Pin,Oertel Michael,Ranganathan Sarangarajan,Singhi Aatur,Rebouissou Sandra,Zucman-Rossi Jessica,Ribback Silvia,Calvisi Diego,Qvartskhava Natalia,Görg Boris,Häussinger Dieter,Chen Xin,Monga Satdarshan P.

Funder

NIH

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference53 articles.

1. From Krebs to clinic: glutamine metabolism to cancer therapy;Altman;Nat. Rev. Cancer,2016

2. Beta-catenin links hepatic metabolic zonation with lipid metabolism and diet-induced obesity in mice;Behari;Am. J. Pathol,2014

3. Apc tumor suppressor gene is the “zonation-keeper” of mouse liver;Benhamouche;Dev. Cell,2006

4. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism;Cadoret;Oncogene,2002

5. Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway;Chafey;Proteomics,2009

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis;Nature Communications;2024-08-30

2. Pyruvate Carboxylase Attenuates Myocardial Ischemia–Reperfusion Injury in Heart Transplantation via Wnt/β-Catenin-Mediated Glutamine Metabolism;Biomedicines;2024-08-12

3. The combination of exon sequencing and metabolomics to establish a molecular typing system for gastric cancer;Heliyon;2024-08

4. Development of Mutated β-catenin Gene Signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCC;JHEP Reports;2024-08

5. Transcriptomic analysis of Paraoxonase 1 expression in hepatocellular carcinoma and its potential impact on tumor immunity;Clinical and Translational Oncology;2024-07-20